HomeCompareBMWYY vs JNJ

BMWYY vs JNJ: Dividend Comparison 2026

BMWYY yields 7.40% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BMWYY wins by $62837.65M in total portfolio value
10 years
BMWYY
BMWYY
● Live price
7.40%
Share price
$29.21
Annual div
$2.16
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$62837.68M
Annual income
$61,247,153,974.64
Full BMWYY calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — BMWYY vs JNJ

📍 BMWYY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBMWYYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BMWYY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BMWYY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BMWYY
Annual income on $10K today (after 15% tax)
$628.78/yr
After 10yr DRIP, annual income (after tax)
$52,060,080,878.44/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, BMWYY beats the other by $52,060,076,892.45/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BMWYY + JNJ for your $10,000?

BMWYY: 50%JNJ: 50%
100% JNJ50/50100% BMWYY
Portfolio after 10yr
$31418.86M
Annual income
$30,623,579,332.02/yr
Blended yield
97.47%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BMWYY
Analyst Ratings
2
Hold
Consensus: Hold
Altman Z
0.8
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BMWYY buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBMWYYJNJ
Forward yield7.40%2.13%
Annual dividend / share$2.16$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28%
Portfolio after 10y$62837.68M$30.3K
Annual income after 10y$61,247,153,974.64$4,689.40
Total dividends collected$62728.70M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: BMWYY vs JNJ ($10,000, DRIP)

YearBMWYY PortfolioBMWYY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$12,179$1,479.49$10,592$272.30+$1.6KBMWYY
2$16,400$3,368.13$11,289$357.73+$5.1KBMWYY
3$26,025$8,477.23$12,123$472.89+$13.9KBMWYY
4$52,992$25,144.88$13,141$629.86+$39.9KBMWYY
5$152,401$95,699.35$14,408$846.81+$138.0KBMWYY
6$677,505$514,436.29$16,021$1,151.60+$661.5KBMWYY
7$4,999,604$4,274,673.75$18,122$1,588.22+$4.98MBMWYY
8$64,311,572$58,961,995.54$20,930$2,228.20+$64.29MBMWYY
9$1,486,472,712$1,417,659,329.93$24,792$3,191.91+$1486.45MBMWYY
10$62,837,679,777$61,247,153,974.64$30,274$4,689.40+$62837.65MBMWYY

BMWYY vs JNJ: Complete Analysis 2026

BMWYYStock

Bayerische Motoren Werke Aktiengesellschaft, together with its subsidiaries, develops, manufactures, and sells automobiles and motorcycles, and spare parts and accessories worldwide. It operates through Automotive, Motorcycles, and Financial Services segments. The Automotive segment is involved in the development, manufacture, assembling, and sale of automobiles, spare parts, accessories, and mobility services under the BMW, MINI, and Rolls-Royce brands. This segment sells its products through independent and authorized dealerships. The Motorcycles segment develops, manufactures, assembles, and sells motorcycles and scooters under the BMW Motorrad brand name, as well as spare parts and accessories. The Financial Services segment engages in automobile leasing, retail and dealership financing, multi-brand fleet, customer deposit, and insurance activities; and the provision of fleet management services under the Alphabet brand. The company was founded in 1916 and is based in Munich, Germany.

Full BMWYY Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this BMWYY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BMWYY vs SCHDBMWYY vs JEPIBMWYY vs OBMWYY vs KOBMWYY vs MAINBMWYY vs ABBVBMWYY vs MRKBMWYY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.